PDA Manufacturing Meets Legislation Workshop 2024
Registration Options
Individual Registration
Group Registration
Program Highlights
The agenda preview is out now!
Join us at this interactive workshop featuring discussions with industry experts and regulatory authorities on challenges and solutions.
Wednesday, 04 September 2024: 13:00-17:00 CEST
Thursday, 05 September 2024: 09:00-17:00 CEST
Friday, 06 September 2024: 09:00-12:00 CEST
Dear Colleague,
We would like to invite you to the PDA Manufacturing Meets Legislation Workshop 2024 to take place from 04-06 September 2024 in Berlin, Germany.
This interactive workshop brings experts from the pharmaceutical industry and the legislative sector together to discuss current challenges and best practices in drug manufacturing following the latest legal regulations. The workshop provides a platform for the exchange of insights on regulatory requirements, quality standards, and compliance strategies crucial to pharmaceutical production. Participants have the opportunity to analyze case studies, develop practical solutions, and gain valuable insights from professionals in the field regarding the implementation of effective manufacturing processes in compliance with legal requirements. A focus is placed on PFAS, integrating innovative technologies and proven methods to enhance product quality while meeting regulatory standards. This workshop promotes collaboration between manufacturers, students, experts, and regulatory authorities to ensure safe, effective, and compliant drug production.
We look forward to welcoming you!
Sincerely,
The Workshop Leader
Stephan Rönninger, Amgen
SCIENTIFIC PROGRAM PLANNING COMMITTEE
- Stephan Rönninger, Amgen
- Veronique Davust, Pfizer
- Jakob Defér, Amgen
- Ana Kuschel, WEST
- Ankur Kulshresthal, BMS
- Miriam Kremer van der Kamp, Vils
- Julian Petersen, groninger
- Falk Klar, PDA Europe
- Stefanie Nebelin, Senior Manager Programs & Events, PDA Europe
Contact
Program Inquiries
Exhibition/Sponsorship Inquiries
Training Course Inquiries
Registration Customer Care
Standard Registration
Member Price
€ 1.080Non-Member
€ 1.080
ALL PRICES IN EURO (EUR), EXCLUDING VAT.
WAYS TO REGISTER: 1. Online Registration 2. registration-europe@pda.org
PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact registration-europe@pda.org before registering.
If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.
Day 1
Wednesday, 04 September 2024
13:00 | Welcome |
Module 1: Preparation for EMA Inspectors Working Group Dialogue |
Introduction to Industry-Regulators Interaction Presentation of the Submitted Topics
|
15:20 | Networking Coffee Break
Discussion Round with Readout |
Summary of Selected Topics |
17:00 | End of Workshop Day 1
Day 2
Thursday, 05 September 2024
Module 2: Impact of Planned PFAS Ban on the Pharmaceutical Industry in Europe |
09:00 | PFAS Materials Used in Pharmaceutical Manufacturing Settings- Potential Supply Chain Risk Overview of the PFAS Situation for their Use in Pharmaceutical Filtration, Opportunities and Risks Considerations for Early-Stage Testing of Chemicals for PFAS Replacement Impact on and Options for Elastomeric Closures on the PFAS Restriction Proposal by ECHA
|
Q&A, Discussion |
10:20 | Networking Coffee Break
Flipchart Activity on PFAS Risk Assessment |
12:00 | Networking Lunch Break
Module 3: Challenges and Opportunities in Pharmaceutical Manufacturing in Europe |
13:00 | PDA’s Initiative for Early Career Professionals Road to Resilience: An Early Career Professional Journey Running the Pharmaceutical Packaging Race |
14:15 | Networking Coffee Break
Innovative Manufacturing Approaches in Europe: From Idea to Implementation EDQM Remote Inspections |
Panel Discussion |
16:20 | End of Workshop Day 2
Day 3
Friday, 06 September 2024
Module 4: Overview of the Current Changes in the EU Regulatory Framework This session will provide an overview of the hot topics changing in the EU legislative framework impacting manufacturing, quality, and supply. |
09:00 I Overview of Upcoming Regulatory Changes Relating to Sustainability Getting to Pharma Organizational Action on Sustainability Q&A, Discussion |
10:00 | Networking Coffee Break
10:30 | Pharmaceutical Manufacturing in the Regulatory Framework |
Panel Discussion General Pharma Legislation ‘License to Operate’ Drug Shortage Prevention |
Key Message: Call to Action Farewell |
11:45 | End of Workshop
Featured Presenters
-
Joachim Almdal
Green Innovation Group
Read BioJoachim Almdal
Green Innovation Group
Joachim Almdal is a partner at Green Innovation Group, a management consulting firm specializing in sustainability within the life sciences and healthcare sectors. He has led numerous sustainability projects across the entire value chain, including maturity assessments of production sites, radical innovation with suppliers, and change management.
-
Bettine Boltres, PhD
Director Scientific Affairs & Technical Solutions, Integrated Systems, West Pharmaceutical Services
Read BioBettine Boltres, PhD
West Pharmaceutical Services
As Director of Scientific Affairs & Technical Solutions, Glass Systems, Dr. Bettine Boltres is supporting the scientific exchange between West and the pharmaceutical industry. This complements her work as Product Manager for Schott Pharmaceutical Tubing, where she provided scientific consulting for glass primary packaging. Since 2015 Bettine has been an active member of the USP Packaging and Distribution Expert Committee as well as the ISO TC76/WG 2 on rigid container systems and WG 4 on elastomers. Additionally, in 2018 joined the European Pharmacopoeia Commission Group of Experts 16 (elastomers and plastics) and the GLS Working Party (glass). Since January 2019 she is also a member of the PDA Board of Directors, actively supporting the role of PDA in the global pharma world. She was part of the PDA Glass Handling Task Force finalizing TR 87, is actively involved in the Task Force working on an Annex to TR 73 addressing MDR GSPRs for PFS, and is part of the Pharmacopeia Interest Group. In 2015 she published the book "When Glass Meets Pharma", which builds the bridge between glass for pharmaceutical primary packaging and drug substances. -
Marion Briggs
Airfield Consulting
Read BioMarion Briggs
Airfield Consulting
Marion Briggs is a circular economy expert, and specialist in medical waste and materials recovery. She currently consults with pharma on initiatives around the regulation and recovery of injection waste for more circular and sustainable processing. She is also the previous Chair of the board of Friends of the Earth, Ireland and remains involved, which allows her to keep abreast of the wider sustainability movement.
-
Ursula Busse, PhD, MBA
Head of Regulatory Affairs, Tigen Pharma
Read BioUrsula Busse, PhD, MBA
Tigen Pharma
Ursula is currently leading Regulatory Affairs for Tigen Pharma, a Swiss biotech company developing autologous T-cell therapies against cancer. Ursula joined Tigen from Boehringer-Ingelheim, where she was Head of Regulatory Intelligence & Policy. Prior to that, Ursula worked at Novartis as Global Head of Quality Intelligence & External Affairs, a role she assumed after a few years as Head of Project Office, Biopharmaceutical Operations, and Project Leader in CMC Regulatory Affairs for biotech products. Before joining Novartis in 2006, Ursula worked for startup biotech companies in Canada, in R&D, Quality Assurance and CMC Regulatory Affairs. Ursula can look back on over 20 years of volunteer engagement in several industry associations (PDA, DIA, ISPE, EFPIA) and served on PDA’s Board of Directors from 2012 to 2017. She holds a PhD in Cellular and Molecular Biology from Laval University (Québec, Canada), coupled with an MBA she earned with honours. -
Oisin Daly
GMP Inspector, EDQM
Read BioOisin Daly
EDQM
Oisín Daly is a GMP Inspector at EDQM, Council of Europe, where he performs inspections of API manufacturing sites, mainly in Asia. Before this, he worked as a GMP Inspector with HPRA, Ireland, performing inspections of both finished dosage forms and API manufacturing sites. During his time working with regulatory authorities, he has been involved in multiple international working groups tasked with developing and revising GMP guidance. He has also previously worked in the pharmaceutical industry, in roles within the area of Manufacturing Science & Technology. He holds M.Sc. degrees in both Pharmacy and Data Analytics.
-
Dieter Hennecke
Head of the Department Ecological Chemistry, Fraunhofer Institute Molecular Biology and Ecotoxicology
Read BioDieter Hennecke
Fraunhofer Institute Molecular Biology and Ecotoxicology
Dr. Dieter Hennecke is since 2008 head of the Department „Ecological Chemistry“ at the Fraunhofer Institute for Molecular Biology and Ecotoxicology (Fraunhofer IME), Germany. He has a doctoral degree (1998) in chemistry and is an expert on the fate, degradation, and metabolism of organic chemicals in environmental matrices in the framework of the respective regulations (pesticides, pharmaceuticals, biocides, REACH). His expertise with 14C-radiolabelling as a means to investigate chemical degradation pathways in complex matrices is one of the key technologies used in this field. He uses it to develop and improve regulatory guidelines, e.g., a long-time member of national and international standardization boards (DIN, ISO).
-
Miriam Kremer van der Kamp
Business Developer, Vils
Read BioMiriam Kremer van der Kamp
Vils
Miriam Kremer-van der Kamp holds a BSc in Engineering in Medical and Pharmaceutical Biotechnology from IMC Krems, Austria. She first gained practical experience working on the integration of VHP decontamination into an existing ceiling module for modular clean rooms. She is currently working as a Business Developer for Vils. Miriam joined PDA in 2022 and is now serving as the ECP Chair for the newly founded DACH Chapter. She was a poster presenter at her first Annual Meeting and is actively involved in promoting professional development and networking opportunities for emerging professionals in the pharmaceutical and biotechnological fields. Miriam is also contributing to organizing various events and initiatives to support the growth and engagement of the PDA community in the region.
-
Ana Kuschel, PhD
Principal Scientific Affairs, West Pharmaceutical Services, Inc.
Read BioAna Kuschel, PhD
West Pharmaceutical Services, Inc.
As Principal Scientific Affairs Europe, Ana is providing technical support relating to West’s packaging components and delivery systems for injectable drugs and healthcare products. As well as bridging scientific information through industry outreach. This complements her previous role as Manager of Material Development, where she worked on both existing and new rubber formulations. Ana holds a PhD in macromolecular chemistry and is an active member of the ISO TC 76 and PDA Packaging Science groups. -
Louise Loughran
Health & Safety Advisor, Eli Lilly and Company
Read BioLouise Loughran
Eli Lilly and Company
Louise holds a master’s degree in occupational Hygiene from the University of Aberdeen, and a postgraduate certificate in chemicals management from the University of Hull, UK. Louise has over 20 years of experience supporting Eli Lilly’s pharmaceutical manufacturing operations in Cork, Ireland. Currently, Louise leads the Lilly EU chemicals management program both at an operations and policy level. Through active participation in pharma chemical experts’ groups, Louise has helped form sector positioning on the revisions of various chemical legislation dossiers - REACH (Registration, Evaluation, Authorisation of Chemicals) and CLP (Classification, Labelling and Packaging) revision, which has been included in stakeholder responses to Commission consultations. Louise regularly participates in Commission stakeholder consultation meetings as an EU Chemicals Expert on behalf of EFPIA, (European Federation of Pharmaceutical Industries Association).
-
Alexander Mitropoulos, PhD
Director of Franchise Portfolio Management, MilliporeSigma
Read BioAlexander Mitropoulos, PhD
MilliporeSigma
Alexander Mitropoulos is the Director of Franchise Portfolio Management, PFAS focus at MilliporeSigma. He has acted as a Senior Product Manager and as a Senior Program Manager for Aseptic Filtration. He has over 14 years of experience in biotechnology and life science working as a researcher, principal investigator, and business manager. He received a B.S. and Ph.D. in Biomedical Engineering from Tufts University in 2010 and 2015 respectively and an MBA from the Isenberg School of Management – University of Massachusetts Amherst in 2024.
Presenters
-
Veronique Davoust, DPharm
Pfizer, Inc.
Veronique Davoust, DPharm
Pfizer, Inc.
Véronique Davoust has over 20 years’ experience in the pharmaceutical industry, both in regulatory affairs and manufacturing, for Pfizer Inc. In her current position,she is responsible for the monitoring and analysis of European emerging regulations and guidelines, especially focusing on Good Manufacturing Practices and registration of the quality section of marketing authorization dossiers throughout the product life cycle, as well as on global topics such as serialization. Véronique ensures the communication and implementation of the guidelines and regulations within the firm, and the coordination of responses to proposed regulatory documents to the competent authorities.
Véronique has been an active member of the PDA for more than 15 years. She was a member of the Board of Directors from 2007 to 2010, and co-chaired the PDA Paradigm Change in Manufacturing Operations (PCMO) project since its creation in 2008. She contributed to the PDA Technical Report No 54: Implementation of Quality Risk Management for Commercial and Biotech Manufacturing Operations.
Véronique recently joined the PDA Regulatory Affairs and Quality Advisory Board and is a frequent lecturer at PDA conferences and meetings.
Véronique is a pharmacist and earned a Doctorate in Pharmacy from the University of Rouen in Normandie, France.
-
Julian Petersen
Head of Global Business Development Pharma, groninger & co. gmbh
Julian Petersen
groninger & co. gmbh
Julian is the Global Head of Business Development Pharma at groninger, a leading fill-finish equipment supplier headquartered in Crailsheim, Germany. Julian actively contributes to the industry as a member of the PDA SAB and co-leader of the PDA Sterile Processing Interest Group. Additionally, Julian is involved in several task force e.g., drafting Points to Consider (PtC) documents on Aseptic Filling and Restricted Access Barrier Systems (RABS). Julian’s industry contribution extends to being the President of the newly founded PDA D/A/CH Chapter. Furthermore, Julian is part of the planning committee of the PDA Annual Meeting and the latest PDA workshop on Manufacturing Meets Legislation. Julian also contributes actively to other industry initiatives in workshops and several speaking opportunities. -
Stephan Rönninger, PhD
Amgen Europe
Stephan Rönninger, PhD
Amgen Europe
Dr. Stephan Rönninger is the 'Head External Affairs Europe, International Quality' of Amgen. He provides leadership, support and represent of external activities impacting Amgen's operations functions. He works with associations in the EU, Japan and emerging markets with focus on Russia and Turkey. He is responsible for advocacy in various external organizations and provides assessment and communication to Amgen.
Stephan Rönninger holds a PhD and an engineering degree in Organic Chemistry. After his postdoctoral studies, he worked for Roche 1992 - 2013, starting in an API manufacturing site with responsibilities for laboratory, project management, as production manager, in Quality Assurance and Quality Management. In 2003, he changed to the Roche Global Quality organization and was responsible for the Global Quality System of Roche and external collaborations.
He represents Amgen in industry trade associations (e.g. EFPIA) and the European industry on GMP/GDP topics as well as at ICH working groups such as Quality Risk Management (ICH Q9), Quality Implementation Working Group (Q-IWG), and the GMP for APIs (ICH Q7) Implementation Working Group. In the Parenteral Drug Association (PDA), he is elected for the board of directors, past chair of the Regulatory Affairs and Quality Advisory Board (RAQAB), leader of the PDA-Europe Inspections Trends Interest group and co-chairs several international conferences and training events (e.g. with PIC/S). He is one of the founders and co-chair of the 'Paradigm Change in Manufacturing Operations' (PCMO) project in PDA.
Sponsorship and Exhibit Opportunities are available!
For more information about exhibit and sponsorship opportunities, please contact:
Christopher Härtig
Manager Exhibition & Sponsorship
Email
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationMedia Partners
PLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
PDA Europe recommends the following hotels in walking distance to the event location, but there are several other hotels in this area. Please note, PDA did not reserve any rooms.
Hotel Indigo Berlin, Ku'damm
Hardenbergstrasse 15
10623 Berlin, Germany
Walking distance from event location three minutes.
Waldorf Astoria Berlin
Hardenbergstrasse 28
10623 Berlin, Germany
Walking distance from event location ten minutes.
Hampton by Hilton Berlin City West
Uhlandstrasse 188-189
10623 Berlin, Germany
Walking distance from event location around five minutes.
How to Get Here
Special Deutsche Bahn Train Fares
Get there relaxed – get there sustainable – travel CO2-free. Your Event Ticket at a fixed price throughout Germany. From any Deutsche Bahn station to our event, with the City-Ticket included.
Event Ticket one-way and specific train (subject to availability):
- 1st class 89,90€ (seat reservation incl.)
- 2nd class 55,90€
Event Ticket one-way and fully flexible:
- 1st class 112,90€ (seat reservation incl.)
- 2nd class 77,90€
Book online now and get the lowest price for your preferred route – guaranteed. For technical questions, please contact the service number +49 (0) 30 58 60 20 901. Create the perfect start for your sustainable event: Make active use of your journey to work or just relax and enjoy the high-speed travel experience – with 100% renewable power on regional and long-distance services.
Book Train